source
- Preoperative intravesical mitomycin C cuts NMIBC recurrence risk by 77% over five yearsA recent study evaluated giving two doses of intravesical mitomycin C before transurethral resection of bladder tumor (TURBT) in patients with non‑muscle‑invasive bladder cancer (NMIBC). Compared…
- FDA Commissioner Marty Makary Resigns, Prompting Concerns Over Agency DirectionFDA Commissioner Marty Makary stepped down on Tuesday, leaving the agency without a permanent leader as it already faces turnover in its drug and biologics divisions. Makary had recently appeared…